Scientists discover new insight into the genetic pathway of neuroblastoma
Researchers from the University of Sheffield have created a stem cell model designed to investigate the origins of neuroblastoma, a...
May 28, 2024
Drug targeting RNA modifications shows promise for treating neuroblastoma
New research from the University of Chicago shows the potential for a promising new approach to treating neuroblastoma by targeting RNA...
May 24, 2024
A new era for treating high-risk neuroblastoma – research advances to look out for in 2024
It's an exciting time for research into high-risk neuroblastoma. Over the past year, multiple trials testing new treatments showed...
May 16, 2024
Neuroblastoma study identifies new subgroups with distinct prognoses and potential vulnerabilities to therapies
Researchers have identified new variations in neuroblastoma that could lead to a more accurate prognosis and better-targeted treatments...
May 7, 2024
Study successfully mimics complex neuroblastoma vasculature on a chip to explore treatments
One of the research focal points of Dr. Josep Samitier's group (Nanobioengineering Group of IBEC), led by Dr. Aránzazu Villasante, is the...
Apr 19, 2024
Change in MYCN-driven cell state opens therapeutic window in high-risk neuroblastoma
A switch between cell states within MYCN-amplified neuroblastoma promotes KDM4, inhibition of which shows promising anticancer potential....
Apr 10, 2024
A team effort delivers a new tool for fighting neuroblastoma
Families of paediatric cancer patients have helped move a pioneering treatment for neuroblastoma from the lab to the clinic. Could this...
Mar 28, 2024
Study identifies patients who benefit most from dinutuximab-based immunotherapy
Using data from a randomized phase III clinical trial of neuroblastoma patients (treated with or without immunotherapy) performed by the...
Mar 26, 2024
Combining CAR-T cells and inhibitor drugs for high-risk neuroblastoma
Roberto Chiarle, MD, at Boston Children's Hospital and his colleagues now report a way to make CAR-T cell therapy work better in...
Mar 7, 2024
Universal, essential biomarker identified for childhood neuroblastoma
Researchers have newly identified a universal, essential biomarker for the childhood cancer neuroblastoma – and a potential new target...
Mar 5, 2024

